ESC 365 - Professor Yong Hoon Kim

Speaker illustration

Professor Yong Hoon Kim

Kangwon National University College of Medicine, Chuncheon (Korea (Republic of))

Member of:

European Society of Cardiology

Diabetes status and grade of left ventricular ejection fraction as predictors of outcomes in patients with Non-ST-segment elevation myocardial infarction

Event: ESC Congress 2025

Topic: Diagnostic Methods

Session: Diabetes and coronary artery disease

The role of left ventricular ejection fraction grade in differentiating outcomes of Non-ST-segment elevation myocardial infarction and ST-segment elevation myocardial infarction

Event: ESC Congress 2025

Topic: Outcome

Session: Acute coronary syndromes and pharmacotherapy

Impact of left ventricular ejection fraction on outcomes in non-ST-segment elevation myocardial infarction patients with and without chronic kidney disease

Event: ESC Congress 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Epidemiology, prognosis, and outcome in chronic heart failure (1)

The impact of left ventricular ejection fraction on 3-year outcomes in patients with coronary chronic total occlusion

Event: ESC Congress 2025

Topic: Revascularisation

Session: Advanced invasive strategies in chronic coronary syndromes

Impact of symptom-to-balloon time on long-term prognosis: a 3-year follow-up study in non-st-segment elevation myocardial infarction patients with complex lesions

Event: ESC Congress 2024

Topic: Revascularisation

Session: Medical and percutaneous treatment of coronary artery disease

Impact of the gender difference on long-term clinical outcomes in dyslipidemic South Korean AMI patients who underwent PCI with new-generation DES

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Acute coronary syndrome

Two-year clinical outcomes between statin with ACE inhibitor or ARB in patients with ST-segment elevation myocardial infarction after successful PCI with DES

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session: Acute coronary syndromes, coronary artery disease: treatment

Three-year major clinical outcomes of phosphorylcholine polymer- versus BioLinx polymer-zotarolimus-eluting stents: A propensity score matching study

Event: ESC Congress 2018

Topic: Stents

Session: Coronary interventions

Angiotensin converting enzyme inhibitor versus angiotensin receptor blockers on the top of calcium channel blocker in development of new-onset diabetes mellitus in hypertensive Korean patients

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Hypertension - Risk profiling and treatment

Hypertension or diabetes; which is worse prognostic factor for acute coronary syndrome patients following percutaneous coronary intervention?

Event: ESC Congress 2017

Topic: CAD and comorbidities

Session: CAD and comorbidities

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources